Clinical Research Organization: Clinical Trials

Rutgers Clinical Research Organization connects industry, patients, and academic collaborators with the university's academic resources. Annually, Rutgers supports approximately 350 clinical trials, including industry-sponsored and our own investigator-initiated studies. In total, more than 200 principal investigators are currently conducting clinical trials in more than 50 therapeutic areas dedicated to moving forward discovery in drugs, biologics, devices, preventive and therapeutic strategies, behavioral research, and other interventions to improve human life.

Advantages

The Rutgers Biomedical and Health Sciences (RBHS) Clinical Research Organization offers key advantages:

  • Access to RBHS schools, centers, and units; to two principal teaching hospitals (Robert Wood Johnson University Hospital and University Hospital); to two university hospitals (Hackensack University Medical Center and University Medical Center at Princeton); and to numerous clinical affiliates statewide.
  • Depth of medical research and clinical expertise—more than 200 principal investigators
  • Full array of core services: clinical lab and analytical services, imaging facilities, data management and analysis
  • Well-developed management skills of all trial phases, including trial design, clinical and medical safety monitoring, recruitment, regulatory affairs
  • Breadth of basic and clinical research activity in all major therapeutic areas
  • Statewide centers of excellence, among them:

Connect with Us

Companies wishing to conduct a clinical trial with an experienced investigator or to gain access to resources to support analysis or help initiating a project can contact the Clinical Research Organization. We will match you with an investigator or the appropriate individuals.